Olshan Client TIG Advisors Joins Allergan Shareholders in Urging Board to Put Acquisitions to Shareholder Vote
September 26, 2014
The Wall Street Journal’s coverage of Allergan’s ongoing defense against a hostile bid by Valeant Pharmaceuticals and Pershing Square reported that Olshan client, TIG Advisors, has delivered a letter to the Board of Directors of Allergan. TIG Advisors joined other Allergan shareholders in urging the Board to put any acquisitions by Allergan to a shareholder vote. The Wall Street Journal had reported earlier this week that Allergan was in advanced talks to acquire Salix Pharmaceuticals in a potentially all-cash deal. Steve Wolosky represents TIG Advisors in connection with its investment in Allergan.